Indian shares plummeted on Friday, with the Sensex and Nifty falling sharply due to global headwinds and U.S. tariffs on Indian exports. Persistent foreign fund outflows and a strengthening dollar further pressured the market. Pharma stocks also suffered following concerns over potential U.S. price regulations. Technical analysis suggests a further downside, with key support levels being closely watched by analysts.
Madhusudan Kela-backed fund buys stake in IPO-bound Steamhouse India for Rs 40 crore
Ace investor Madhusudan Kela’s funds, along with Niveshaay Sambhav Fund, have injected Rs 49.99 crore into Steamhouse India via a pre-IPO placement. This strategic investment